NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE226408 Query DataSets for GSE226408
Status Public on Mar 15, 2023
Title Tumor Suppressor Role of INPP4B in Chemoresistant Retinoblastoma
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Chemotherapy of retinoblastoma (RB), a malignant ocular childhood disease, is often limited by the development of resistances against commonly used drugs. We identified inositol polyphosphate 4-phosphatase type II (INPP4B) as a differentially regulated gene in etoposide resistant RB cell lines, potentially involved in the development of RB resistances. INPP4B is controversially discussed as a tumor suppressor and an oncogenic driver in various cancers, but its role in retinoblastoma in general and chemoresistant RB in particular is yet unknown. In the study presented, we investigated the expression of INPP4B in RB cell lines and patients and analyzed the effect of INPP4B overexpression on etoposide resistant RB cell growth in vitro and in vivo. INPP4B mRNA levels were significantly downregulated in RB cells lines compared to the healthy human retina, with even lower expression levels in etoposide resistant compared to the sensitive cell lines. Besides, a significant increase in INPP4B expression was observed in chemotherapy treated RB tumor patient samples compared to untreated tumors. INPP4B overexpression in etoposide resistant RB cells resulted in a significant reduction in cell viability with reduced growth, proliferation, anchorage-independent growth, and in ovo tumor formation. Caspase-3/7 mediated apoptosis was concomitantly increased, suggesting a tumor suppressive role of INPP4B in chemoresistant RB cells. No changes in AKT signalling were discernible, but p-SGK3 levels increased following INPP4B overexpression, indicating a potential regulation of SGK3 signalling in etoposide-resistant RB cells. RNAseq analysis of INPP4B overexpressing, etoposide resistant RB cell lines revealed differentially regulated genes involved in cancer progression, mirroring observed in vitro and in vivo effects of INPP4B overexpression and strengthening INPP4B`s importance for cell growth control and tumorigenicity.
 
Overall design Two cell lines Y79_Etop and RB355_Etop. Three biological replicates (n=3). INPP4B lentiviral overexpression (INPP4B) versus control (K).
Web link https://www.hindawi.com/journals/jo/2023/2270097/
 
Contributor(s) Miroschnikov N, Dräger O, Van Meenen D, Budeus B, Dünker N, Busch M, Metz K
Citation(s) 36993823
Submission date Mar 01, 2023
Last update date Jun 14, 2023
Contact name Bettina Budeus
E-mail(s) bettina.budeus@uk-essen.de
Organization name University Hospital Essen
Department Institute for Cell Biology
Lab GTF
Street address Virchowstrasse 173
City Essen
ZIP/Postal code 45147
Country Germany
 
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
Samples (12)
GSM7074624 Y79_Etop, control, rep1
GSM7074625 Y79_Etop, control, rep2
GSM7074626 Y79_Etop, control, rep3
Relations
BioProject PRJNA940148

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE226408_raw_counts.csv.gz 757.0 Kb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap